Acute Biphenotypic Leukemia: Clinical Trials

11 trials for Acute Biphenotypic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed. 11 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 211Completed 11
Phase 12Completed 2

Follow Acute Biphenotypic Leukemia: new trials by email Literature Review of Acute Biphenotypic Leukemia trials Research Report on Acute Biphenotypic Leukemia

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma
Anti-Thymocyte Globulin, Busulfan, Clofarabine - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia
Phase 2CompletedM.D. Anderson Cancer Center62017-10-132023-10-11
Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant
Ibrutinib, Laboratory Biomarker Analysis - Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia
Phase 2CompletedAndrew Rezvani82017-09-122023-08-01
Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Cladribine, Cytarabine, Filgrastim - Acute Biphenotypic Leukemia, Acute Myeloid Leukemia
Phase 1 / Phase 2CompletedUniversity of Washington842016-12-012023-07-05
Nivolumab and Azacitidine With or Without Ipilimumab in Treating Patients With Refractory/Relapsed or Newly Diagnosed Acute Myeloid Leukemia
Azacitidine, Ipilimumab, Venetoclax - Acute Bilineal Leukemia, Acute Biphenotypic Leukemia
Phase 2CompletedM.D. Anderson Cancer Center1502015-04-072025-06-08
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD
Allogeneic Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Fludarabine Phosphate - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia
Phase 2CompletedFred Hutchinson Cancer Center842015-03-232026-06-01
Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute Leukemia
Clofarabine, Cytarabine, Dexamethasone - Acute Bilineal Leukemia, Acute Biphenotypic Leukemia
Phase 2CompletedM.D. Anderson Cancer Center162014-10-272024-03-22
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children
Allogeneic Hematopoietic Stem Cell Transplantation, Fludarabine Phosphate, Laboratory Biomarker Analysis - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia
Phase 2CompletedFred Hutchinson Cancer Center202014-04-102024-03-12
Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Cladribine, Cytarabine, Filgrastim - Acute Biphenotypic Leukemia, de Novo Myelodysplastic Syndrome
Phase 1 / Phase 2CompletedFred Hutchinson Cancer Center1992014-01-232020-01-10
Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes
Cyclophosphamide, Cyclosporine, Ex Vivo-Expanded Cord Blood Progenitor Cell Infusion - Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission
Phase 2CompletedNohla Therapeutics, Inc.1632012-12-112021-07-06
Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant
Cyclosporine, Fludarabine Phosphate, Laboratory Biomarker Analysis - Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission
Phase 2CompletedFred Hutchinson Cancer Center1302009-02-242023-02-17
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease
Cyclophosphamide, Cyclosporine, Double-Unit Umbilical Cord Blood Transplantation - Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia
Phase 2CompletedFred Hutchinson Cancer Center1352005-11-182025-03-07

Narrower conditions

Leukemia, Biphenotypic, Acute (11)  ·  Leukemia, Myeloid, Acute (8)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (7)  ·  Myelodysplastic Syndromes (6)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (5)  ·  Leukemia, Myeloid, Accelerated Phase (3)  ·  Anemia, Refractory, with Excess of Blasts (2)  ·  Blast Crisis (2)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Leukemia, Myeloid, Chronic-Phase (2)  ·  Leukemia, Myelomonocytic, Chronic (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Anemia, Refractory (1)  ·  Blastic Plasmacytoid Dendritic Cell Neoplasm (1)  ·  Burkitt Lymphoma (1)

Broader conditions

Hematologic Diseases (11)  ·  Hemic and Lymphatic Diseases (11)  ·  Immune System Diseases (11)  ·  Immunoproliferative Disorders (11)  ·  Leukemia (11)  ·  Leukemia, Lymphoid (11)  ·  Lymphatic Diseases (11)  ·  Lymphoproliferative Disorders (11)  ·  Neoplasms (11)  ·  Neoplasms by Histologic Type (11)  ·  Leukemia, Myeloid (10)  ·  Bone Marrow Diseases (9)  ·  Chronic Disease (8)  ·  Disease Attributes (8)  ·  Pathologic Processes (8)

Interventions

Whole-Body Irradiation (6)  ·  Mycophenolic Acid (5)  ·  Cord Blood Stem Cell Transplantation (4)  ·  Cyclophosphamide (4)  ·  Thiotepa (4)  ·  fludarabine phosphate (4)  ·  Cyclosporine (3)  ·  Cytarabine (3)  ·  Filgrastim (3)  ·  Granulocyte Colony-Stimulating Factor (3)  ·  Tacrolimus (3)  ·  CT-P10 (2)  ·  Cladribine (2)  ·  Clofarabine (2)  ·  Cyclosporins (2)

Sponsors

Fred Hutchinson Cancer Center (5)  ·  M.D. Anderson Cancer Center (3)  ·  Andrew Rezvani (1)  ·  Nohla Therapeutics, Inc. (1)  ·  University of Washington (1)

Countries

United States (11)

Top investigators

Filippo Milano (2)  ·  Marie Bleakley (2)  ·  Amanda Olson (1)  ·  Andrew Rezvani (1)  ·  Ann E. Dahlberg (1)  ·  Anna Halpern (1)  ·  Elias Jabbour (1)  ·  Naval Daver (1)  ·  Roland Walter (1)

Results publications

PMID 35007144, PMID 32706891, PMID 34980577, PMID 37339483, PMID 38391202

NIH funding

P30CA015704 (3), P01CA018029 (2), R01HL121568 (2), K23CA154532 (1), P50HL110787 (1)